Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2017; 24(3): 246-252


Evaluation of IL-32 levels in gingival tissue and serum of experimental periodontitis model

Figen Ongoz Dede, Umut Balli, Mustafa Cenk Durmuslar, Seyma Bozkurt Dogan, Bahattin Avci, Bulent Ayas, Ozgur Korhan Tuncel.




Abstract
Cited by 1 Articles

Aim: Interleukin (IL)-32, a recently discovered proinflammatory cytokine, is demonstrated in several infectious diseases. The goal
of this study is to investigate the levels of IL-6, IL-10 and IL-32 in gingival tissue and serum of rats with experimental periodontitis.
Material and Methods: Experimental periodontitis was induced by placing a silk ligature around the cervix of both sides of mandibular
first molars in each male rat except for control group (Group 1). Thirty male Wistar albino rats were randomly divided into three
groups of ten animals each as experimental periodontitis groups (Group 2, ligated for seven days; Group 3, ligated for fourteen days)
and periodontally healthy control group (Group 1). At the end of experimental period, rats were sacrificed, and histomorphometric
analyses were performed on the mandibles. IL-32, IL-10 and IL-6 levels were measured in gingival tissue and serum samples by
ELISA.
Results: Alveolar bone and attachment loss were statistically higher in all experimental groups than those in control group (P

Key words: Interleukin-32; Experimental Periodontitis; Gingiva; Serum.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.